Stocks and Investing
Stocks and Investing
Thu, December 1, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 30, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John Sourbeer Initiated (WST) at Hold and Held Target at $250 on, Nov 30th, 2022
John Sourbeer of UBS, Initiated "West Pharmaceutical Services, Inc." (WST) at Hold and Held Target at $250 on, Nov 30th, 2022.
John has made no other calls on WST in the last 4 months.
There are 2 other peers that have a rating on WST. Out of the 2 peers that are also analyzing WST, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Derik De Bruin of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $250 on, Friday, October 28th, 2022
This is the rating of the analyst that currently disagrees with John
- Paul Knight of "Keybanc" Maintained at Buy with Decreased Target to $350 on, Friday, October 28th, 2022
Contributing Sources